David Lunt, Chief Financial Officer

As Chief Financial Officer, David Lunt oversees financial planning and analysis, accounting, tax, procurement, and treasury. David brings to the Institute more than 20 years of extensive experience in the field. Prior to The Institute for Neurodegenerative Disorders, he was Director of Financial Planning and analysis at Cogstate, where he was responsible for overseeing all aspects of the Clinical Trials segment planning functions, including customer proposals and change orders. Previously, David worked at Molecular NeuroImaging / Invicro as Director of Finance, as well as Walker Digital in various business unit finance roles.  David has earned a bachelor’s and master’s degree in accounting from Merrimack College.